Comparative study of mifepristone and misoprostol versus misoprostol alone in induction of labour in late intrauterine fetal death

Hemalatha K. R., Qutejatul Kubra Mulla


Background: Intrauterine fetal death is most undesirable consequence of pregnancy and stressful condition for women and family and for health professional. Naturally, majority of women (over 90%) go in for spontaneous labour and deliver within 3 weeks of intrauterine death. Prolonged retention of dead fetus in utero has complications like DIC, psychological stress and infection. Various methods are available to induce labor in intrauterine fetal death. One such regimen is medical management using a combination of Mifepristone and Misoprostol. The objective of this study was to compare efficacy and safety of combination of mifepristone and misoprostol versus misoprostol only in induction of labour in late intrauterine fetal death.

Methods: A prospective study was carried out in KIMS, Hubli between Jan 2014 to Dec 2015.Data from 100 women with intrauterine fetal death between gestational age of 24-42 weeks were analysed. They were divided into 2 groups of 50 each. Group I received single oral dose of 200mg mifepristone followed 24 hours later with oral misoprostol (100µg-50µg) every 4 hourly. Group II received only misoprostol. Outcomes were measured in terms of induction to delivery interval and number of misoprostol doses required.

Results: Mean induction to delivery interval in Group I was 8.3 hours versus13.4 hours in Group II. Induction delivery interval was shorter in combined regimen. Total dose of misoprostol was also less in Group I.

Conclusions: Both regimens are safe for induction of labour in late intrauterine fetal death. However, the induction delivery interval and dose of misoprostol required was decreased in combination regimen.


Late intrauterine fetal death, Induction of labour, Mifepristone, Misoprostol

Full Text:



Mehl LE, Bruce CE, Renner JH. Indicator of quality of care in international comparisons. J Farm Pract 1976;3:385-9.

Pritchard JA. Fetal death in utero. Obstet Gynaecol. 1959;14:573-80.

Fletcher HM, Wharfe G, Simeon D, Mitchell S, Brown D. Induction of labour with intravaginal misoprostol versus dinoprostone in intrauterine death: a retrospective study. J Obstet Gynaecol. 1996;16:155-8.

Bugalho A, Bique C, Machungo F, Faaundes A. Induction of labour with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynaecol. 1994;171:538-41.

Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second trimester termination and intrauterine death. Best Pract Res Clin Obstet Gynaecol. 2003;17(5):765-75.

Newhall EP, Winikof B. Abortion with mifepristone and misoprostol: regimen efficacy, acceptability and future directions Am J Obstet Gynaecol. 2000;182:44-53.

El- Refacy H, Rajashekhar. D, Abdalla M, Calder T, Templeton A, Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol N Engl J M. 1995;332:983-7.

Ashok PW, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Human Reprod.1998;13(100):2962-5.

Cabrol D, Dubois C, Cronje H, Gonnet JM, Guillot M, Maria B et al. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynaecol. 1990;163:540-2.

Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG: Int J Obstet Gynaecol. 2002 Apr 1;109(4):443-7.

Fairley TE, Mackenzie M, Owen P, Mackenzie F. Management of late intrauterine fetal death using a combination of mifepristone and misoprostol-experience of two regimens. Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):28-31.

Vayrynen W, Heikinheimo O, Nuutila M. Misoprostol only versus mifepristone plus misoprostol in induction of labour following intrauterine fetal death. Acta Obstet Gynecol Scand. 2007;86(6):701-5.

Sharma D, Singhal SR, Poonam, Paul A, Kunika, Tai. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death. J Obstet Gynaecol. 2011;50:322-5.